COVID-19

Excerpt from the article: “As a researcher who develops vaccines for emerging infectious diseases, UConn pathobiologist and associate professor Paulo Verardi pays close attention to the news. He was doing just that in mid-January when he noticed that a new coronavirus SARS-CoV-2, causing a disease now known as coronavirus disease 2019 or COVID-19, was starting…

Excerpt from the FDA News Release: Today, the U.S. Food and Drug Administration issued the first emergency use authorization for a point-of-care COVID-19 diagnostic for the Cepheid Xpert Xpress SARS-CoV-2 test. “The test we’re authorizing today will be able to provide Americans with results within hours, rather than days like the existing tests, and the…

Excerpt from the article: “At the Berlin X-ray source BESSY II, researchers have decoded the protein responsible for the replication of the corona virus. Analysing the 3D architecture allows the systematic development of drugs which inhibit the reproduction oft he virus.” Click the button below to read the entire article! Continue To The Article

Excerpt from the article: “With a coronavirus vaccine at least a year away, some scientists are investigating existing medicines and compounds that might work as effective treatments. A drug called remdesivir is now in the spotlight, but health professionals, and scientists say it’s too soon to know if it really works against COVID-19.” Click the…

Excerpt from the article: “We have recently reported that two drugs, remdesivir (GS-5734) and chloroquine (CQ) phosphate, efficiently inhibited SARS-CoV-2 infection in vitro1. Remdesivir is a nucleoside analog prodrug developed by Gilead Sciences (USA). A recent case report showed that treatment with remdesivir improved the clinical condition of the first patient infected by SARS-CoV-2 in…

The U.S. Food and Drug Administration today issued a guidance for industry, investigators and institutional review boards conducting clinical trials during the coronavirus (COVID-19) pandemic. Click the button below to read the entire Guidance from the FDA! Continue Reading The Guidance

New research finds that the virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and on surfaces. Scientists found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detectable in aerosols for up to three hours, up to four hours on copper, up to 24 hours on cardboard…

Melbourne researchers have mapped immune responses from one of Australia’s first novel coronavirus (COVID-19) patients, showing the body’s ability to fight the virus and recover from the infection UNIVERSITY OF MELBOURNE Click the button below to read the entire article! Continue To The Article